only with
Jubilant Ingrevia Ltd.
Jubilant Ingrevia
Jubilant Ingrevia Ltd. live price is ₹ 0.00. Price change 0.00, 0.00 percent.
₹ 0.00
0.00 (0.00)%
Chemicals
Small-cap - With a market cap of ₹100.71 Cr.
| EX-Date | Purpose |
|---|---|
| 07 06 2021 | Dividend & Audited Results |
| 20 07 2021 | Quarterly Results |
| 19 10 2021 | Quarterly Results |
| 02 12 2021 | Inter alia, to consider buy-back of 1,000 7.90% Secured, Rated, Listed, Redeemable Non- Convertible Debentures of Rs. 10,00,000 (Rupees Ten Lac) each aggregating to Rs. 100 Crore. |
| 01 02 2022 | Quarterly Results & Interim Dividend |
| 13 05 2022 | Inter alia, to consider change in Terms and Conditions including early redemption/ buyback of 1,000 7.90% Secured, Rated, Listed, Redeemable NonConvertible Debentures of Rs. 10,00,000 (Rupees Ten Lac) each aggregating to Rs. 100 Crore |
| 17 05 2022 | Final Dividend & Audited Results |
| 05 08 2022 | Quarterly Results |
| 20 10 2022 | Quarterly Results |
| 31 01 2023 | Quarterly Results & Interim Dividend |
| 16 05 2023 | Jubilant Ingrevia Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 ,inter alia, to consider and approveIn terms of Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ListingRegulations ), we wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, May 16, 2023, to inter-aliaconsider: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31, 2023; and 2. Recommendation ofFinal Dividend for the Financial Year ended March 31, 2023, if any. |
| 26 07 2023 | Quarterly Results |
| 18 08 2023 | Inter-alia, to consider a proposal for raising of funds through Commercial Papers. |
| 01 11 2023 | Quarterly Results |
| 30 01 2024 | Quarterly Results & Interim Dividend |
| 22 10 2024 | Quarterly Results |
| 28 01 2025 | Interim Dividend & Quarterly Results |
| 13 05 2025 | Final Dividend & Audited Results |
| 31 07 2025 | Quarterly Results |
| 27 10 2025 | Quarterly Results |
| 04 02 2026 | Quarterly Results |
| 26 05 2026 | Final Dividend & Audited Results |
| 22 07 2026 | Quarterly Results |
News
Jubilant Ingrevia informs about disclosure
Jubilant Ingrevia inches up on inking pact to acquire 40% stake in Zettaone Technologies India
The cost of acquisition is Rs 189.2 crore
Jubilant Ingrevia inks pact to acquire 40% stake in Zettaone Technologies India
The cost of acquisition is Rs 189.2 crore
Jubilant Ingrevia informs about newspaper publication
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia informs about press release
Jubilant Ingrevia informs about financial results
Jubilant Ingrevia informs about grant of stock options under ESOS
Jubilant Ingrevia reports Profit after tax of Rs 1262.20 Mln, in the June 2026 quarter
Jubilant Ingrevia informs about compliance report
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 1052.20 Mln, in the March 2026 quarter
Jubilant Ingrevia zooms on acquiring 100% equity stake in Remidex Pharma
This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4)
Jubilant Ingrevia acquires 100% equity stake in Remidex Pharma
This acquisition will enable Jubilant Ingrevia to move forward in the value chain towards Premixes in Human Nutrition Space building upon its leadership position in Vitamins (Vitamin B3 & B4)
Jubilant Ingrevia’s arm begins commercial production of Agro Intermediate at Bharuch Site
The dispatch of material has started from March 21, 2026
Jubilant Ingrevia inks pact to acquire 100% stake in Remidex Pharma
Cost of acquisition is Rs 16.5 crore subject to customary closing conditions
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 597.10 Mln, in the December 2025 quarter
Jubilant Ingrevia submits analyst meet intimation
Jubilant Ingrevia informs about earnings call transcript
Jubilant Ingrevia submits newspaper publication
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 440.30 Mln, in the September 2025 quarter
Jubilant Ingrevia informs about issuance of CP
Jubilant Ingrevia raises Rs 50 crore through Commercial Papers
Maturity of the said Commercial Papers will be on November 21, 2025
Jubilant Ingrevia informs about disclosure
Jubilant Ingrevia informs about investors meet
Jubilant Ingrevia informs about credit rating
Jubilant Ingrevia informs about record date of CP
Jubilant Ingrevia gains on raising Rs 50 crore through Commercial Papers
Maturity date of the said Commercial Papers is September 25, 2025
Jubilant Ingrevia raises Rs 50 crore through Commercial Papers
Maturity date of the said Commercial Papers is September 25, 2025
Jubilant Ingrevia informs about board meeting
Jubilant Ingrevia informs about change in management
Jubilant Ingrevia informs about unaudited financial results
Jubilant Ingrevia informs about outcome of board meeting
Jubilant Ingrevia informs about press release
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 590.10 Mln, in the June 2025 quarter
Jubilant Ingrevia raises Rs 70 crore through Commercial Papers
Tenure of the instrument is 55 days
Jubilant Ingrevia informs about issuance of CP
Jubilant Ingrevia moves up on raising Rs 50 crore through Commercial Papers
Tenure of the instrument is 60 days
Jubilant Ingrevia raises Rs 50 crore through Commercial Papers
Tenure of the instrument is 60 days
Jubilant Ingrevia informs about disclosures
Jubilant Ingrevia informs about disclosure
Jubilant Ingrevia raises Rs 50 crore through Commercial Papers
Tenure of the instrument is 60 days
Jubilant Ingrevia submits newspaper publication
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 898.70 Mln, in the March 2025 quarter
Jubilant Ingrevia gains on signing power purchase agreement with O2 Power
This agreement reinforces the company’s commitment to sustainability through the adoption of green energy
Jubilant Ingrevia signs power purchase agreement with O2 Power
This agreement reinforces the company’s commitment to sustainability through the adoption of green energy
Jubilant Ingrevia informs about interim dividend
Jubilant Ingrevia informs about analyst meet
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 806.00 Mln, in the December 2024 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia informs about press release
Jubilant Ingrevia commissions new cGMP compliant facility in Gujarat
The facility is an extension of the company’s USFDA approved plant that is already supplying to the U.S., Europe, Japan and many other markets
Jubilant Ingrevia informs about scrutinizers report
Jubilant Ingrevia shines as its arm gets nod to purchase 6.67% stake in Forum I Aviation
The company at its Board Meeting held on December 30, 2024 has approved the same
Jubilant Ingrevia’s arm gets nod to purchase 6.67% stake in Forum I Aviation
The company at its Board Meeting held on December 30, 2024 has approved the same
Jubilant Ingrevia raises Rs 48 crore through Commercial Papers
Tenure of the instrument is 60 days
Jubilant Ingrevia informs about postal ballot notice
Jubilant Ingrevia surges on raising Rs 100 crore through commercial papers
The maturity of the said Commercial Papers will be on February 24, 2025
Jubilant Ingrevia raises Rs 100 crore through commercial papers
The maturity of the said Commercial Papers will be on February 24, 2025
Jubilant Ingrevia informs about presentation
Jubilant Ingrevia informs about superannuation of co-CEO & whole-time director
Jubilant Ingrevia informs about appointment of CEO and managing director
Jubilant Ingrevia informs about outcome of board meeting
Jubilant Ingrevia reports Profit after tax of Rs 601.80 Mln, in the September 2024 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia zooms after its arm inks pact to produce Agro Intermediate
Jubilant Agro Sciences has entered into an agreement with a leading Agrochemical Company
Jubilant Ingrevia’s arm inks pact to produce Agro Intermediate
Jubilant Agro Sciences has entered into an agreement with a leading Agrochemical Company
Jubilant Ingrevia soars on raising Rs 100 crore through Commercial Papers
Tenure of the instrument is 90 days
Jubilant Ingrevia raises Rs 100 crore through Commercial Papers
Tenure of the instrument is 90 days
Jubilant Ingrevia informs about press release
Jubilant Ingrevia rises on commissioning new facility for Diketene derivatives in Uttar Pradesh
The newly commissioned facility adds additional capacity of 2,000 TPA to produce high-value esters
Jubilant Ingrevia commissions new facility for Diketene derivatives at Uttar Pradesh
The newly commissioned facility adds additional capacity of 2,000 TPA to produce high-value esters
Jubilant Ingrevia inks pact with O2 Renewable Energy XVIII
This partnership marks a significant step for the company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
Jubilant Ingrevia surges on commissioning agro active & intermediate plant in Gujarat
The plant is geared towards meeting the rising future global demand for agro actives & intermediates
Jubilant Ingrevia commissions agro active & intermediate plant in Gujarat
The plant is geared towards meeting the rising future global demand for agro actives & intermediates
Jubilant Ingrevia raises Rs 50 crore through Commercial Papers
Date of maturity of the said Commercial Papers is March 27, 2024
Jubilant Ingrevia informs about outcome of board meeting
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 193.30 Mln, in the December 2023 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia’s arm purchases 6.67% stake in Forum I Aviation
Post-acquisition, JIL holds 9.12% equity shares in FAPL
Jubilant Ingrevia informs about disclosure
Jubilant Ingrevia gains on commissioning Mutipurpose Agro Intermediate Plant for Value Added Derivatives
The plant aims to cater to the growing demand of agro intermediates across the globe
Jubilant Ingrevia commissions Mutipurpose Agro Intermediate Plant for Value Added Derivatives
The plant aims to cater to the growing demand of agro intermediates across the globe
Jubilant Ingrevia informs about updates
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 573.20 Mln, in the September 2023 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia raises Rs 100 crore through Commercial Papers
The aggregate amount of Commercial Papers (including this issue) outstanding as on date is Rs 300 crore
Jubilant Ingrevia raises Rs 100 crore through Commercial Papers
The maturity of the said Commercial Papers will be on November 2, 2023
Jubilant Ingrevia informs about outcome of board meeting
Jubilant Ingrevia gets nod to raise Rs 600 crore via commercial papers
The members of the Finance Committee, at its meeting held on August 18, 2023 has considered and approved the same
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 548.20 Mln, in the June 2023 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia raises Rs 125 crore through Commercial Papers
The tenure of instrument is 55 days and hence the maturity will be on September 18, 2023
Jubilant Ingrevia soars on raising Rs 100 crore via commercial papers
The tenure of instrument is 55 days and hence the maturity will be on July 20, 2023
Jubilant Ingrevia raises Rs 100 crore via commercial papers
The tenure of instrument is 55 days and hence the maturity will be on July 20, 2023.
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 386.70 Mln, in the March 2023 quarter
Jubilant Ingrevia submits analyst meet intimation
Jubilant Ingrevia gains on raising Rs 50 crore via commercial papers
The tenure of instrument is 49 days and hence the maturity will be on June 26, 2023
Jubilant Ingrevia raises Rs 50 crore via commercial papers
The tenure of instrument is 49 days and hence the maturity will be on June 26, 2023
Jubilant Ingrevia raises Rs 50 crore via Commercial Papers
The tenure of instrument is 66 days and hence the maturity will be on June 29, 2023
Jubilant Ingrevia gains on commissioning new Acetic Anhydride plant in Gujarat
This facility augmentation will further strengthen the relationship that Jubilant Ingrevia enjoys with its global clients
Jubilant Ingrevia commissions new Acetic Anhydride plant in Gujarat
This facility augmentation will further strengthen the relationship that Jubilant Ingrevia enjoys with its global clients
Jubilant Ingrevia informs about compliance certificate
Jubilant Ingrevia informs about disclosure
Jubilant Ingrevia moves higher on acquiring 37.98% stake in Mister Veg Foods
Aggregate consideration for acquisition of additional shares is Rs 2.12 crore
Jubilant Ingrevia acquires 37.98% stake in Mister Veg Foods
Aggregate consideration for acquisition of additional shares is Rs 2.12 crore
Jubilant Ingrevia gains on raising Rs 150 crore via CPs
The tenure of instrument is 49 days and hence the maturity will be on March 30, 2023
Jubilant Ingrevia raises Rs 150 crore via CPs
The tenure of instrument is 49 days and hence the maturity will be on March 30, 2023
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 679.40 Mln, in the December 2022 quarter
Jubilant Ingrevia informs about confirmation certificate
Jubilant Ingrevia informs about record date
Jubilant Ingrevia informs about redemption of CP
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia reports Profit after tax of Rs 703.60 Mln, in the September 2022 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia informs about outcome of AGM
Jubilant Ingrevia surges on raising Rs 50 crore via CPs
The tenure of instrument is 59 days and hence the maturity will be on October 28, 2022
Jubilant Ingrevia raises Rs 50 crore via CPs
The tenure of instrument is 59 days and hence the maturity will be on October 28, 2022
Jubilant Ingrevia raises Rs 50 crore via CPs
The tenure of instrument is 46 days and hence the maturity will be on October 10
Jubilant Ingrevia informs about updates
Jubilant Ingrevia reports Profit after tax of Rs 764.40 Mln, in the June 2022 quarter
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia - Quaterly Results
Jubilant Ingrevia gains on raising Rs 25 crore through Commercial Papers
Date of maturity of said Commercial Papers will be August 30, 2022
Jubilant Ingrevia raises Rs 25 crore through Commercial Papers
Date of maturity of said Commercial Papers will be August 30, 2022